SS

Somveer Singh

Active Director Director DIN 08609618
DIN 08609618 First appointment Nov 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Somveer Singh

Data last updated:

Somveer Singh is a Director at Blaine Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Blaine Pharmaceuticals Private Limited reported revenue of ₹2.73 Cr (FY 2024).

DIN 08609618
Primary Designation Director
Industry Trading
First Appointment 14 Nov 2019
Oldest Company Age 7 yrs
Largest company Blaine Pharmaceuticals Private Limited · ₹2.73 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Nov 20192019₹2.73 Cr (FY 2024)Active

Board colleagues of Somveer Singh

Directorship timeline

Open interactive timeline →
Blaine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Somveer Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Somveer Singh

Somveer Singh currently holds 1 directorship: Blaine Pharmaceuticals Private Limited (Director, since 14 Nov 2019, revenue ₹2.73 Cr (FY 2024)).

Somveer Singh was first appointed on 14 Nov 2019 as Director at Blaine Pharmaceuticals Private Limited.

The current boards of Somveer Singh's companies include Deepak (Blaine Pharmaceuticals Private Limited), Mayank Kumar (Blaine Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available